https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-23 / Int. J. Oncol. 2018 Apr;52(4):1041-1056
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-23 / Int. J. Oncol. 2018 Apr;52(4):1041-10562018-02-23 00:00:002019-02-15 08:32:54Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-25 / Front Pharmacol 2017;8:495
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-25 / Front Pharmacol 2017;8:4952017-07-25 00:00:002019-02-15 08:32:55Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-12 / Onco Targets Ther 2017;10:2097-2106
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-12 / Onco Targets Ther 2017;10:2097-21062017-04-12 00:00:002019-02-15 08:34:49Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-21 / J Neurooncol 2017 04;132(2):255-266
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-21 / J Neurooncol 2017 04;132(2):255-2662017-01-21 00:00:002021-11-15 20:06:08Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-07-12 / Cytotherapy 2016 09;18(9):1178-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-07-12 / Cytotherapy 2016 09;18(9):1178-862016-07-12 00:00:002020-06-23 10:01:20Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-04 / Prog Tumor Res 2015;42:11-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-04 / Prog Tumor Res 2015;42:11-212015-09-04 00:00:002019-02-15 08:34:50Immunotherapy of Brain Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / CNS Oncol 2014;3(5):337-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / CNS Oncol 2014;3(5):337-482014-01-01 00:00:002019-02-15 08:32:55Diffuse intrinsic pontine glioma: time for therapeutic optimism
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-05-01 / Anticancer Res. 2013 May;33(5):2047-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-05-01 / Anticancer Res. 2013 May;33(5):2047-562013-05-01 00:00:002019-02-15 08:34:51Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-04-01 / Pediatr Blood Cancer 2010 Apr;54(4):519-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-04-01 / Pediatr Blood Cancer 2010 Apr;54(4):519-252010-04-01 00:00:002021-11-15 14:45:11Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / APMIS 2006 Oct;114(10):731-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / APMIS 2006 Oct;114(10):731-432006-10-01 00:00:002006-10-01 00:00:00Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid
